强生Johnson & Johnson (JNJ) 2023年CSR报告「NYSE」.pdf

1、2023 Health for Humanity ReportThe Health Care CompanyArti Gajanan Modshe,a student in the Indian Red Cross Society Auxiliary Nurses and Midwives(ANM)Training Program,supported by the Johnson&Johnson Foundation,puts her training to work in a home visit in rural India OurapproachScientists at work at

2、 a J&J Innovative Medicine laboratory in China32023 Health for Humanity ReportGRI 2-22 Message from our leadersTo our global community,2023 was a transformational year for Johnson&Johnson.In separating our Consumer Health business,we reoriented our company to focus on the worlds toughest health chal

3、lenges through scientific innovation and technology.Our Innovative Medicine and MedTech businesses are now operating under the Johnson&Johnson name.Together our more than 130,000 employees are building a world where complex diseases are prevented,treated and cured,treatments are smarter and less inv

4、asive,and solutions are personal.While Johnson&Johnson evolves to address the most pressing needs of patients,our purpose remains the same.For more than 80 years,Our Credo has reminded us of our responsibilities to the people we serve:patients,doctors and nurses,employees,communities and investors.I

5、n 2023,our Executive Committee and Board of Directors spoke with Credo stakeholders to understand their expectations for Johnson&Johnson as we enter this new chapter in our evolution.Their message was clear:Johnson&Johnson is unique in our industry,and our Health for Humanity priorities should refle

6、ct that.Our Health for Humanity strategy reflects our focus on driving the next wave of medical innovation,while championing global health equity,empowering our employees and advancing environmental health.A key element is our use of data science and technology,which are transforming our business.Am